GlassScriptPhysician profile
Rahul Pannala
NPI 1124034970
$45,240.92
in general payments reported to CMS, 2019-2025
11 companies · $6,055 in 2025
The $6,055 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2021: $790 · 2022: $2,843 · 2023: $6,612 · 2024: $29K · 2025: $6,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $7,315 · Education: $4,750 · Travel and Lodging: $2,258 · Food and Beverage: $1,178 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,590.78 |
| Honoraria | $7,315.00 |
| Education | $4,750.00 |
| Travel and Lodging | $2,258.00 |
| Food and Beverage | $1,178.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $24,590.78 | 2024 | Single Use Repositionable Clip |
| Aimmune Therapeutics, INC. | $9,625.00 | 2022-2024 | |
| Intuitive Surgical, INC. | $5,700.35 | 2025 | |
| Boston Scientific Corporation | $3,001.60 | 2019-2025 | Exalt Model D, Axios, Apollo Esg Nxt System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,625.00 | 2021-2023 | Xifaxan, Plenvu, Trulance |
| Medtronic, INC. | $233.85 | 2022-2024 | Nexpowder |
| Fujifilm Healthcare Americas Corporation | $231.65 | 2024 | Fujifilm |
| Apollo Endosurgery US INC | $124.82 | 2019 | |
| Surgical Theater. INC. | $93.00 | 2021 | |
| Merck Sharp & Dohme LLC | $14.87 | 2023 | Dificid |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Pannala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.